The renin-angiotensin-aldosterone system and myocardial collagen matrix remodelling in congestive heart failure.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  European Heart Journal

• Publication date

  1995-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/EURHEARTJ/16.SUPPL_O.107PMID 8682074
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone.

  1994cited by this paper
• Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism.

  1993cited by this paper
• Identification of Functional Angiotensin II Receptors on Rat Cardiac Fibroblasts

  1993cited by this paper
• Interstitial collagen is increased in the non-infarcted human myocardium after myocardial infarction.

  1993cited by this paper
• Reactive and reparative myocardial fibrosis in arterial hypertension in the rat.

  1992cited by this paper
• Pathological Hypertrophy and Cardiac Interstitium: Fibrosis and Renin‐Angiotensin‐Aldosterone System

  1991cited by this paper
• Impaired diastolic function and coronary reserve in genetic hypertension. Role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries.

  1991cited by this paper
• Cardioreparative Effects of Lisinopril in Rats With Genetic Hypertension and Left Ventricular Hypertrophy

  1991cited by this paper
• Myocardial fibrosis and pathologic hypertrophy in the rat with renovascular hypertension.

  1990cited by this paper
• Regulation of fibrillar collagen types I and III and basement membrane type IV collagen gene expression in pressure overloaded rat myocardium.

  1990cited by this paper
• Stretching cardiac myocytes stimulates protooncogene expression.

  1990cited by this paper
• Fibrillar collagen and remodeling of dilated canine left ventricle.

  1990cited by this paper
• Remodeling of the rat right and left ventricles in experimental hypertension.

  1990cited by this paper
• Localization of types I, III and IV collagen mRNAs in rat heart cells by in situ hybridization.

  1989cited by this paper
• Stimulation of collagen formation by insulin and insulin-like growth factor I in cultures of human lung fibroblasts.

  1989cited by this paper
• The effect of PGE2 on the activation of quiescent lung fibroblasts.

  1987cited by this paper
• The effect of transforming growth factor-beta on cell proliferation and collagen formation by lung fibroblasts.

  1987cited by this paper
• Muscle fiber orientation and connective tissue content in the hypertrophied human heart.

  1982cited by this paper
• Myocyte Hypertrophy in Neonatal Rat Heart Cultures and Its Regulation by Serum and by Catecholamines

  1982cited by this paper
• Regulation of collagen production by the beta-adrenergic system.

  1981cited by this paper

• Efficacy of low dose colchicine on left ventricular hypertrophy in patients with coronary artery disease: A randomized controlled trial.

  2026cites this paper
• Artificial intelligence-enabled printed electrochemical biosensors for detection of cardiovascular disease

  2026cites this paper
• Global Research Trends in Oxidative Stress and Myocardial Fibrosis: A Dual-Software Bibliometric Study

  2025cites this paper
• Targeting the E Prostanoid Receptor EP4 Mitigates Cardiac Fibrosis Induced by β‐Adrenergic Activation

  2025cites this paper
• Research progress on programmed cell death of cardiomyocytes in pressure-overload hypertrophic cardiomyopathy

  2025cites this paper
• Efficacy and safety of combining a thiazide diuretic with a loop diuretic in decompensated heart failure: A systematic review and meta-analysis

  2025cites this paper
• Hyperpolarization‐activated cyclic nucleotide‐gated channel inhibitor in myocardial infarction: Potential benefits beyond heart rate modulation

  2024cites this paper
• Proinflammatory indicators and the relevance of echocardiography in children with cystic fibrosis.

  2023cites this paper
• A narrative review on sacubitril/valsartan and ventricular arrhythmias

  2022cites this paper
• Heart Failure with Preserved Ejection Fraction in Children

  2022cites this paper
• Therapeutic Approaches in Heart Failure with Preserved Ejection Fraction (HFpEF) in Children: Present and Future

  2022cites this paper
• Editorial on “Cardiac involvement in cystic fibrosis evaluated using cardiopulmonary magnetic resonance”. Cardiac involvement in cystic fibrosis: more than a lung-related disease?

  2022cites this paper
• Caveolin-1 Deficiency Induces Atrial Fibrosis and Increases Susceptibility to Atrial Fibrillation by the STAT3 Signaling Pathway

  2021cites this paper
• Lutein attenuates angiotensin II- induced cardiac remodeling by inhibiting AP-1/IL-11 signaling

  2021cites this paper
• Cardiovascular System Involvement in Cystic Fibrosis

  2021cites this paper
• Factors affecting the urinary aldosterone-to-creatinine ratio in healthy dogs and dogs with naturally occurring myxomatous mitral valve disease

  2021cites this paper
• SIRT1-mediated deacetylation of NF-κB inhibits the MLCK/MLC2 pathway and the expression of ET-1 thus alleviating the development of coronary artery spasm.

  2020cites this paper
• Impact of renin–angiotensin system inhibitors on outcomes after transcatheter aortic valve replacement: A meta‐analysis

  2020cites this paper
• Advanced electrocardiography in myocardial electrical remodeling : insights from cardiovascular magnetic resonance imaging

  2020cites this paper
• A Genomic Study of Myxomatous Mitral Valve Disease in Cavalier King Charles Spaniels

  2020cites this paper
• Human pluripotent stem cell-derived cardiac stromal cells and their applications in regenerative medicine.

  2020cites this paper
• Angiotensin II induces apoptosis of cardiac microvascular endothelial cells via regulating PTP1B/PI3K/Akt pathway

  2019cites this paper
• Kaempferol Prevents Against Ang II-induced Cardiac Remodeling Through Attenuating Ang II-induced Inflammation and Oxidative Stress

  2019cites this paper
• The renin‐angiotensin‐aldosterone system and its suppression

  2019cites this paper
• Impact of renin-angiotensin system inhibitors on clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis of from the PARTNER 2 trial and registries.

  2019cites this paper
• Diabetic cardiomyopathy - A comprehensive updated review.

  2019cites this paper
• Effect of etelcalcetide on cardiac hypertrophy in hemodialysis patients: a randomized controlled trial (ETECAR-HD)

  2019cites this paper
• Incidence of hospital-acquired hyponatremia by the dose and type of diuretics among patients with acute heart failure and its association with long-term outcomes.

  2018cites this paper
• Emphasis on abdominal obesity as a modifier of eplerenone effect in heart failure: hypothesis‐generating signals from EMPHASIS‐HF

  2017cites this paper
• Effect of eplerenone in patients with heart failure and reduced ejection fraction: potential effect modification by abdominal obesity. Insight from the EMPHASIS‐HF trial

  2017cites this paper
• Association of Renal Resistive Index, Renal Pulsatility Index, Systemic Hypertension, and Albuminuria with Survival in Dogs with Pituitary-Dependent Hyperadrenocorticism

  2016cites this paper
• Evaluation of subacute change in RAAS activity (as indicated by urinary aldosterone:creatinine, after pharmacologic provocation) and the response to ACE inhibition

  2016cites this paper
• Taxonomy of segmental myocardial systolic dysfunction

  2016cites this paper
• FGF 23 from bench to bedside

  2016cites this paper
• FGF23 from bench to bedside.

  2016cites this paper
• Effects of high doses of enalapril and benazepril on the pharmacologically activated renin-angiotensin-aldosterone system in clinically normal dogs.

  2015cites this paper
• Telmisartan inhibited angiotensin II-induced collagen metabolic imbalance without directly targeting TGF-β 1/Smad signaling pathway in cardiac fibroblasts.

  2015cites this paper
• Aldosterone breakthrough with benazepril in furosemide-activated renin-angiotensin-aldosterone system in normal dogs.

  2015cites this paper
• Hypertensive Heart Disease and Obesity: A Complex Interaction Between Hemodynamic and Not Hemodynamic Factors

  2014cites this paper
• Effet du Valsartan sur 3 marqueurs inflammatoires chez le sujet SAOS : comparaison à la CPAP

  2013cites this paper
• le sujet SAOS : comparaison a la CPAP

  2013cites this paper
• Effect of furosemide and high-dosage pimobendan administration on the renin-angiotensin-aldosterone system in dogs.

  2013cites this paper
• Pathophysiology of diastolic dysfunction in chronic heart failure.

  2013cites this paper
• Eplerenone for the treatment of cardiovascular disorders

  2012cites this paper
• Molecular and Cellular Effects of Nutrition on Disease Processes

  2012cites this paper
• Physiological regulation of extracellular matrix collagen and elastin in the arterial wall of rats by noradrenergic tone and angiotensin II

  2012cites this paper
• Aldosterone Receptor Antagonists for Hypertension

  2012cites this paper
• Stimulation of reactive oxygen species and collagen synthesis by angiotensin II in cardiac fibroblasts.

  2012cites this paper
• Myocardial fibrosis in left ventricular non‐compaction: is late gadolinium enhancement indeed indicative of fibrosis?

  2011cites this paper
• Myocardial strain assessment in cystic fibrosis.

  2011cites this paper
• Prevalence of renal artery stenosis in flash pulmonary oedema: determination using gadolinium-enhanced MRA.

  2010cites this paper
• Angiotensin II-activated protein kinase D mediates acute aldosterone secretion.

  2010cites this paper
• Baicalein and Wogonin inhibit collagen deposition in SHR and WKY cardiac fibroblast cultures.

  2010cites this paper
• Aldosterone receptor antagonists--how cardiovascular actions may explain their beneficial effects in heart failure.

  2010cites this paper
• Air pollution and cardiac remodeling: a role for RhoA/Rho-kinase.

  2009cites this paper
• Regulation of cardiac fibroblast collagen synthesis by adenosine: roles for Epac and PI3K.

  2009cites this paper
• A propensity-matched study of low serum potassium and mortality in older adults with chronic heart failure.

  2009cites this paper
• Central Mineralocorticoid Receptors and Cardiovascular Disease

  2009cites this paper
• Cardiac fibroblasts: at the heart of myocardial remodeling.

  2009cites this paper
• Late myocardial remodeling in cardiac allografts: challenges and opportunities.

  2009cites this paper
• Endothelial Dysfunction: From Molecular Mechanisms to Measurement, Clinical Implications, and Therapeutic Opportunities

  2008cites this paper
• LONG-TERM MODIFICATIONS IN LEFT VENTRICULAR STRUCTURE AND FUNCTION AFTER ADRENALECTOMY OR MEDICAL TREATMENT IN PATIENTS WITH PRIMARY

  2008cites this paper
• A propensity-matched study of the effects of chronic diuretic therapy on mortality and hospitalization in older adults with heart failure.

  2008cites this paper
• A new methodological approach to assess cardiac work by pressure–volume and stress–length relations in patients with aortic valve stenosis and dilated cardiomyopathy

  2007cites this paper
• A propensity-matched study of the association of low serum potassium levels and mortality in chronic heart failure.

  2007influential citation
• Effect of angiotensin II on primary cardiac fibroblast matrix metalloproteinase activities

  2007cites this paper
• Chapter 85 – Novel Drug Treatments for Hypertension

  2007cites this paper
• Patients who have dilated cardiomyopathy must have a trial of bridge to recovery (pro).

  2007cites this paper
• Modulation of the tissue reninangiotensin-aldosterone system in dogs with chronic mild regurgitation through the mitral valve.

  2007cites this paper
• Novel therapies blocking the renin–angiotensin–aldosterone system in the management of hypertension and related disorders

  2007cites this paper
• Serial analysis of troponin I levels in patients with ischemic and nonischemic dilated cardiomyopathy

  2006cites this paper
• Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods.

  2006cites this paper
• Aldosterone Antagonism in an Inflammatory State: Evidence for Myocardial Protection

  2006cites this paper
• Effect of potassium canrenoate, an anti-aldosterone agent, on incidence of ascites and variceal progression in cirrhosis.

  2006cites this paper
• Mecanismo de acción de la eplerenona

  2006cites this paper
• Impact of right ventricular size on ECG after percutaneous closure of atrial septal defect with Amplatzer Septal Occluder.

  2005cites this paper
• Natriuretic Peptides

  2005cites this paper
• Spironolactone is not Effective for the Treatment of Hypokalemia in Peritoneal Dialysis Patients

  2005cites this paper
• Additive amelioration of left ventricular remodeling and molecular alterations by combined aldosterone and angiotensin receptor blockade after myocardial infarction.

  2005cites this paper
• Characterization of mechanisms of myocardial remodeling in genetic models of cardiac hypertrophy

  2005cites this paper
• Combined angiotensin receptor blocker and ACE inhibitor on myocardial fibrosis and left ventricular stiffness in dogs with heart failure.

  2004cites this paper
• Long-term outcome of patients with acromegaly and congestive heart failure.

  2004cites this paper
• Effects of aldosterone receptor antagonist and angiotensin II type I receptor blocker on cardiac transcriptional factors and mRNA expression in rats with myocardial infarction.

  2004cites this paper
• Physical Exercise in Patients with Heart Failure Due to Myocarditis and Dilated Cardiomyopathy

  2004cites this paper
• Eplerenone in the treatment of chronic heart failure

  2004cites this paper
• [Physical activity and sports in heart failure due to myocarditis and dilated cardiomyopathy].

  2004cites this paper
• Candesartan Prevents Myocardial Fibrosis during Progression of Congestive Heart Failure

  2004cites this paper
• The prognosis of impaired left ventricular systolic function and heart failure in a middle‐aged and elderly population in an urban population segment of Copenhagen

  2004cites this paper
• Angiotensin II Enhances Adenylyl Cyclase Signaling via Ca2+/Calmodulin

  2003cites this paper
• Aldosterone receptor antagonists for hypertension: what do they offer?

  2003cites this paper
• Can Angiotensin-converting Enzyme Inhibitors Reverse Atherosclerosis?

  2003cites this paper
• Left ventricular diastolic function in patients with advanced cystic fibrosis.

  2003cites this paper
• Role of intracardiac renin-angiotensin-aldosterone system in extracellular matrix remodeling.

  2003cites this paper
• Wirkung der AT2-Überexpression auf Collagen I alpha 2-mRNA-Gehalt und Migration porciner kardialer Fibroblasten

  2003cites this paper
• [Diabetic cardiopathy: pathogenesis, diagnosis and therapy].

  2003cites this paper
• Rapid Effects of Aldosterone and Spironolactone in the Isolated Working Rat Heart

  2002cites this paper
• The cardiac fibroblast, another therapeutic target for mending the broken heart?

  2002cites this paper
• Stellenwert der Aldosteronrezeptorblockade in der diuretischen Therapie von Patienten mit chronischer Herzinsuffizienz

  2002influential citation
• Review: The potential benefits of aldosterone antagonism in Type 2 diabetes mellitus

  2002cites this paper
• Angiotensin receptor blockers: how important is selectivity?

  2002cites this paper